Weather forecast

Over the wall 📶

To go: Johnson & Johnson willing to pay $2 billion to buy Ambrx Biopharma.

Euronomics: European banks will most likely outperform on returns versus US banks for the time being.

Baby issue: Johnson & Johnson has agreed to pay $700 million to settle an investigation into its talc-based baby powder.

Cost of business: India may take a hit on ar…